| Literature DB >> 34397218 |
Ajay Vikram Singh1, Romi Singh Maharjan1, Charlotte Kromer1, Peter Laux1, Andreas Luch1, Tanusri Vats2, Vaisali Chandrasekar3, Sarada Prasad Dakua3, Byung-Wook Park4.
Abstract
The inhalation toxicology of multifaceted particulate matter from the environment, cigarette smoke, and e-cigarette liquid vapes is a major research topic concerning the adverse effect of these items on lung tissue. In vitro air-liquid interface (ALI) culture models hold more potential in an inhalation toxicity assessment. Apropos to e-cigarette toxicity, the multiflavor components of the vapes pose a complex experimental bottleneck. While an appropriate ALI setup has been one part of the focus to overcome this, parallel attention towards the development of an ideal exposure system has pushed the field forward. With the advent of microfluidic devices, lung-on-chip (LOC) technologies show enormous opportunities in in vitro smoke-related inhalation toxicity. In this review, we provide a framework, establish a paradigm about smoke-related inhalation toxicity testing in vitro, and give a brief overview of breathing LOC experimental design concepts. The capabilities with optimized bioengineering approaches and microfluidics and their fundamental pros and cons are presented with specific case studies. The LOC model can imitate the structural, functional, and mechanical properties of human alveolar-capillary interface and are more reliable than conventional in vitro models. Finally, we outline current perspective challenges as well as opportunities of future development to smoking lungs-on-chip technologies based on advances in soft robotics, machine learning, and bioengineering.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34397218 DOI: 10.1021/acs.chemrestox.1c00219
Source DB: PubMed Journal: Chem Res Toxicol ISSN: 0893-228X Impact factor: 3.739